Algert Global’s BioLife Solutions BLFS Stock Holding History

Algert Global’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,116	Closed	-$546K	–	1096
2023 Q1	$546K	Sell	25,116 -31,843	-56%	-$716K	0.03%	799
2022 Q4	$1.04M	Sell	56,959 -9,661	-15%	-$199K	0.06%	555
2022 Q3	$1.52M	Sell	66,620 -34,521	-34%	-$739K	0.09%	374
2022 Q2	$1.4M	Buy	+101,141	New	+$1.48M	0.11%	337
2022 Q1	–	Sell	-12,150	Closed	-$453K	–	1185
2021 Q4	$453K	Buy	+12,150	New	+$521K	0.06%	575

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Algert Global's BLFS Position: Q2 2023 in Review

Algert Global sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 25,116 shares — an estimated $546K sold.

Algert Global first reported a position in BLFS in Q4 2021 and held it in 5 quarters. The position peaked at $1.52M in Q3 2022. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

Algert Global reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
Algert Global sold 25,116 BioLife Solutions shares in Q2 2023, an estimated $546K.
Algert Global first reported a position in BioLife Solutions in Q4 2021 and held it in 5 quarters.
Algert Global's BioLife Solutions position peaked at $1.52M in Q3 2022.
156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Algert Global's 13F filing for Q2 2023, filed 14 Aug 2023.